Abstract
Purpose: To evaluate the delivered spinal cord dose on CALGB 39808, which used induction Topotecan/Paclitaxel x 2 cycles, followed by chemoradiotherapy (Carboplatinum/Etoposide with 60 – 70 Gy TRT) for limited stage small cell lung cancer, a phase II study.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.